JGC
SPPI

J. Goldman & Co’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

J. Goldman & Co’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-267,801
Closed -$2.34M – 349
2018
Q4 		$2.34M Sell
267,801
-141,625
-35% -$1.8M 0.18% 131
2018
Q3 		$6.88M Sell
409,426
-284,912
-41% -$6.17M 0.48% 62
2018
Q2 		$14.6M Buy
694,338
+221,902
+47% +$4.11M 0.75% 35
2018
Q1 		$7.6M Buy
472,436
+205,957
+77% +$4.08M 0.32% 82
2017
Q4 		$5.05M Buy
266,479
+81,504
+44% +$1.48M 0.27% 106
2017
Q3 		$2.6M Buy
+184,975
New +$1.67M 0.13% 174
2015
Q2 		– Sell
-63,000
Closed -$382K – 349
2015
Q1 		$382K Buy
+63,000
New +$419K 0.02% 254

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

J. Goldman & Co's SPPI Position: Q1 2019 in Review

J. Goldman & Co sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2019, closing a stake of 267,801 shares — an estimated $2.34M sold.

J. Goldman & Co first reported a position in SPPI in Q1 2015 and held it in 7 quarters. The position peaked at $14.6M in Q2 2018. 173 funds tracked by Wall St. Rank hold SPPI as of Q1 2019.

  • J. Goldman & Co reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2019 after selling out during the quarter.
  • J. Goldman & Co sold 267,801 Spectrum Pharmaceuticals Inc shares in Q1 2019, an estimated $2.34M.
  • J. Goldman & Co first reported a position in Spectrum Pharmaceuticals Inc in Q1 2015 and held it in 7 quarters.
  • J. Goldman & Co's Spectrum Pharmaceuticals Inc position peaked at $14.6M in Q2 2018.
  • 173 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2019.

Based on J. Goldman & Co's 13F filing for Q1 2019, filed 14 May 2019.